249 Targeting IFNβ-regulated secretory profiles to overcome acquired anti-PD-L1 resistance

by Yuhao Shi, Melissa Dolan, Michalis Mastri, Kevin Eng, John Ebos
Published 2020-11-01

Enhanced efficacy of sitravatinib in metastatic models of antiangiogenic therapy resistance.

by Melissa Dolan, Michalis Mastri, Amanda Tracz, James G Christensen, Gurkamal Chatta, John M L Ebos
Published 2019-01-01

USP1 Regulates TAZ Protein Stability Through Ubiquitin Modifications in Breast Cancer

by Ashley Mussell, He Shen, Yanmin Chen, Michalis Mastri, Kevin H. Eng, Wiam Bshara, Costa Frangou, Jianmin Zhang
Published 2020-10-01

A Transient Pseudosenescent Secretome Promotes Tumor Growth after Antiangiogenic Therapy Withdrawal

by Michalis Mastri, Amanda Tracz, Christina R. Lee, Melissa Dolan, Kristopher Attwood, James G. Christensen, Song Liu, John M.L. Ebos
Published 2018-12-01

Population modeling of tumor growth curves and the reduced Gompertz model improve prediction of the age of experimental tumors.

by Cristina Vaghi, Anne Rodallec, Raphaëlle Fanciullino, Joseph Ciccolini, Jonathan P Mochel, Michalis Mastri, Clair Poignard, John M L Ebos, Sébastien Benzekry
Published 2020-02-01